![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Mol. Neurosci. , 27 September 2023
Sec. Brain Disease Mechanisms
Volume 16 - 2023 | https://doi.org/10.3389/fnmol.2023.1294087
This article is a correction to:
Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy
by Li, N., Ma, R.-H., Zhang, E.-F., Ge, F., Fang, D.-Y., Zhang, J., Zhang, Y.-N., Gao, Y., Hou, L.-C., and Jin, H.-X. (2023). Front. Mol. Neurosci. 16:1182005. doi: 10.3389/fnmol.2023.1182005
In the published article, there was an error in the order of the corresponding authors. Instead of “Li-Chao Hou, aG91bGljaGFvaGxjNkAxMjYuY29t; Hong-Xu Jin, amluaG9uZ3h1bmpoeDhAMTI2LmNvbQ==”, it should be in the correct order of “Hong-Xu Jin, amluaG9uZ3h1bmpoeDhAMTI2LmNvbQ==; Li-Chao Hou, aG91bGljaGFvaGxjNkAxMjYuY29t”. We should also state Hong-Xu Jin is responsible for the integrity of the work as a whole. Li-Chao Hou contributes equally to this study as common corresponding author.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: sepsis-associated encephalopathy (SAE), recombinant human brain natriuretic peptide (rhBNP), interferon-induced transmembrane protein 3 (IFITM3), inflammation, apoptosis
Citation: Li N, Ma R-H, Zhang E-F, Ge F, Fang D-Y, Zhang J, Zhang Y-N, Gao Y, Hou L-C and Jin H-X (2023) Corrigendum: Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy. Front. Mol. Neurosci. 16:1294087. doi: 10.3389/fnmol.2023.1294087
Received: 14 September 2023; Accepted: 15 September 2023;
Published: 27 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Li, Ma, Zhang, Ge, Fang, Zhang, Zhang, Gao, Hou and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hong-Xu Jin, amluaG9uZ3h1bmpoeDhAMTI2LmNvbQ==; Li-Chao Hou, aG91bGljaGFvaGxjNkAxMjYuY29t
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.